NASDAQ:AVAH - Aveanna Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $14.65
  • Forecasted Upside: 106.05 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 8 Buy Ratings
  • 1 Strong Buy Ratings
$7.11
▲ +0.2 (2.89%)

This chart shows the closing price for AVAH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aveanna Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVAH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVAH

Analyst Price Target is $14.65
▲ +106.05% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Aveanna Healthcare in the last 3 months. The average price target is $14.65, with a high forecast of $20.00 and a low forecast of $10.00. The average price target represents a 106.05% upside from the last price of $7.11.

This chart shows the closing price for AVAH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 contributing investment analysts is to buy stock in Aveanna Healthcare.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 1 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/23/2021
  • 1 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/21/2021
  • 1 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/21/2021

Latest Recommendations

  • 1 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/13/2021Truist SecuritiesLower Price TargetBuy$15.00 ➝ $10.00Low
10/13/2021TruistLower Price TargetBuy$15.00 ➝ $10.00Low
5/24/2021Truist SecuritiesInitiated CoverageBuy$15.00High
5/24/2021BMO Capital MarketsInitiated CoverageOutperform$17.00Medium
5/24/2021Jefferies Financial GroupInitiated CoverageBuy$15.00Medium
5/24/2021JPMorgan Chase & Co.Initiated CoverageNeutral$14.00Medium
5/24/2021Royal Bank of CanadaInitiated CoverageOutperform$16.00Medium
5/24/2021Credit Suisse GroupInitiated CoverageOutperform$16.00Medium
5/24/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$13.50Medium
5/24/2021Raymond JamesInitiated CoverageStrong-Buy$15.00Medium
5/24/2021BarclaysInitiated CoverageOverweight$20.00Medium
5/24/2021TruistInitiated CoverageBuy$15.00Medium
(Data available from 10/21/2016 forward)

News Sentiment Rating

-0.20 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/24/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/24/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/23/2021
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/21/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
10/21/2021

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 7 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Aveanna Healthcare logo
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which our caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; unskilled nursing services; and employer of record support services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers a line of durable medical equipment and enteral nutrition supplies to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Read More

Today's Range

Now: $7.11
Low: $6.87
High: $7.16

50 Day Range

MA: $8.48
Low: $6.47
High: $10.00

52 Week Range

Now: $7.11
Low: $6.40
High: $13.00

Volume

876,396 shs

Average Volume

665,660 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Aveanna Healthcare?

The following Wall Street sell-side analysts have issued research reports on Aveanna Healthcare in the last year: Barclays PLC, BMO Capital Markets, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Raymond James, Royal Bank of Canada, Truist, Truist Securities, and Zacks Investment Research.
View the latest analyst ratings for AVAH.

What is the current price target for Aveanna Healthcare?

10 Wall Street analysts have set twelve-month price targets for Aveanna Healthcare in the last year. Their average twelve-month price target is $14.65, suggesting a possible upside of 112.0%. Barclays PLC has the highest price target set, predicting AVAH will reach $20.00 in the next twelve months. Truist has the lowest price target set, forecasting a price of $10.00 for Aveanna Healthcare in the next year.
View the latest price targets for AVAH.

What is the current consensus analyst rating for Aveanna Healthcare?

Aveanna Healthcare currently has 1 hold rating, 8 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AVAH will outperform the market and that investors should add to their positions of Aveanna Healthcare.
View the latest ratings for AVAH.

What other companies compete with Aveanna Healthcare?

Other companies that are similar to Aveanna Healthcare include LHC Group, Option Care Health, AdaptHealth, Signify Health, Addus HomeCare, Apria, APR Energy, Cancer Treatment and New York Health Care.

How do I contact Aveanna Healthcare's investor relations team?

Aveanna Healthcare's physical mailing address is 400 INTERSTATE NORTH PARKWAY STE 1700, ATLANTA GA, 30339. The company's listed phone number is 770-441-1580 and its investor relations email address is [email protected] The official website for Aveanna Healthcare is www.aveanna.com.